Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders. The company's first development candidate Ecopipam, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome.Emalex Biosciences was founded in 2018 by Jeff Aronin.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 3, 2020 | Debt Financing | $15M | 1 | Horizon Technology Finance | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Horizon Technology Finance | Yes | Debt Financing |